Brozena S - Search Results

1

Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure. Results of a multicenter trial. The Pimobendan Multicenter Research Group.

Kubo SH, Gollub S, Bourge R, Rahko P, Cobb F, Jessup M, Brozena S, Brodsky M, Kirlin P, Shanes J, et al. Kubo SH, et al. Among authors: brozena s. Circulation. 1992 Mar;85(3):942-9. doi: 10.1161/01.cir.85.3.942. Circulation. 1992. PMID: 1537130 Clinical Trial.

2

New Management Strategies in Heart Failure.

Owens AT, Brozena SC, Jessup M. Owens AT, et al. Among authors: brozena sc. Circ Res. 2016 Feb 5;118(3):480-95. doi: 10.1161/CIRCRESAHA.115.306567. Circ Res. 2016. PMID: 26846642 Review.

3

Heart failure.

Jessup M, Brozena S. Jessup M, et al. Among authors: brozena s. N Engl J Med. 2003 May 15;348(20):2007-18. doi: 10.1056/NEJMra021498. N Engl J Med. 2003. PMID: 12748317 Review. No abstract available.

4

A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.

Katz SD, Kubo SH, Jessup M, Brozena S, Troha JM, Wahl J, Cohn JN, Sonnenblick EH, LeJemtel TH. Katz SD, et al. Among authors: brozena s. Am Heart J. 1992 Jan;123(1):95-103. doi: 10.1016/0002-8703(92)90752-h. Am Heart J. 1992. PMID: 1729854 Clinical Trial.

5

Treatment of advanced heart failure.

Jessup M, Brozena S. Jessup M, et al. Among authors: brozena s. Cardiol Rev. 2000 May-Jun;8(3):148-57. Cardiol Rev. 2000. PMID: 11174888 Review.

6

Pathophysiologic strategies in the management of congestive heart failure.

Brozena S, Jessup M. Brozena S, et al. Annu Rev Med. 1990;41:65-74. doi: 10.1146/annurev.me.41.020190.000433. Annu Rev Med. 1990. PMID: 2184749 Review.

7

Identification and management of potential heart transplant recipients.

Jessup M, Brozena SC. Jessup M, et al. Among authors: brozena sc. Cardiol Clin. 1990 Feb;8(1):11-21. Cardiol Clin. 1990. PMID: 2407353 Review.

8

The new staging system for heart failure. What every primary care physician should know.

Brozena SC, Jessup M. Brozena SC, et al. Geriatrics. 2003 Jun;58(6):31-6; quiz 38. Geriatrics. 2003. PMID: 12813870 Review.

9

Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.

Horwitz PA, Tsai EJ, Putt ME, Gilmore JM, Lepore JJ, Parmacek MS, Kao AC, Desai SS, Goldberg LR, Brozena SC, Jessup ML, Epstein JA, Cappola TP. Horwitz PA, et al. Among authors: brozena sc. Circulation. 2004 Dec 21;110(25):3815-21. doi: 10.1161/01.CIR.0000150539.72783.BF. Epub 2004 Dec 6. Circulation. 2004. PMID: 15583081

10

Neprilysin Inhibitors: Emerging Therapy for Heart Failure.

Owens AT, Brozena S, Jessup M. Owens AT, et al. Among authors: brozena s. Annu Rev Med. 2017 Jan 14;68:41-49. doi: 10.1146/annurev-med-052915-015509. Epub 2016 Sep 21. Annu Rev Med. 2017. PMID: 27686019 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page